tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Income Statement

Compare
286 Followers

Enliven Therapeutics Income Statement

Last quarter (Q4 2024), Enliven Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Enliven Therapeutics's net income was $-23.18M. See Enliven Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -297.00K$ -622.00K$ -99.00K$ -97.00K
Operating Expenses
$ 104.55M$ 83.53M$ 38.79M$ 24.76M$ 9.32M
Depreciation and Amortization
$ 0.00$ 297.00K$ 215.00K$ 115.00K$ 97.00K
EBITDA
$ -104.55M$ -81.93M$ -38.58M$ -24.65M$ -9.27M
Operating Income
$ -104.55M$ -83.53M$ -38.79M$ -24.76M$ -9.32M
Other Income/Expenses
$ 15.30M$ 11.95M$ 1.13M$ 22.00K$ -9.65M
Pretax Income
$ -89.26M$ -71.58M$ -37.66M$ -24.74M$ -18.97M
Net Income
$ -89.02M$ -71.58M$ -37.75M$ -24.72M$ -18.93M
Per Share Metrics
Basic EPS
$ -1.89$ -2.01$ -6.03$ -3.17$ -14.14
Diluted EPS
$ -1.89$ -2.01$ -6.03$ -3.17$ -14.14
Weighted Average Shares Outstanding
47.07M 35.55M 6.25M 7.81M 3.48M
Weighted Average Shares Outstanding (Diluted)
47.07M 35.55M 6.25M 7.81M 3.48M
Currency in USD

Enliven Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis